It is believed that people with MCI are at high risk of developing Alzheimer disease.

It is believed that people with MCI are at high risk of developing Alzheimer disease. Related StoriesBU researcher gets prestigious fellowship to launch new project for people with dementiaResearchers find that stem cell treatment may decrease cognitive impairment linked to dementia with Lewy bodiesEstrogen-like drug might not be good for women with Alzheimer's dementiaDr Raschetti and co-workers at Italy’s National Centre for Epidemiology, Surveillance and Health Advertising in Rome conducted a systematic review of the data from clinical trials that had addressed the usage of cholinesterase inhibitors with MCI individuals.The disease is the effect of a mutation in the CFTR gene entirely on chromosome 7. This mutation causes elevated secretion deposits on mucous membranes. Lung problems represent the most severe manifestation of the condition – and the reason behind the high mortality price amongst patients. Such complications involve infection of the bronchi by the bacteria Pseudomonas aeruginosa often. Chronic inflammations then trigger lung functions to be blocked. Aside from the break-down of lung cells, this results in bronchiectasis and lung failure also. Axentis Pharma AG Axentis Pharma AG is normally a Swiss biotechnology organization.